AOD-9604Q, a synthetic fragment of human growth hormone (hGH), has read more emerged as a novel therapeutic candidate for addressing various musculoskeletal disorders. Its targeted mechanism of action involves activating with the growth hormone receptor, primarily stimulating collagen synthesis and enhancing bone density. Preclinical studies have